Skip to Main Content

We have a new app!

Take the Access library with you wherever you go—easy access to books, videos, images, podcasts, personalized features, and more.

Download the Access App here: iOS and Android. Learn more here!

Inherited disease of the purine catabolism resulting in deficient T-cell immunity, and often in neurologic symptoms as well.

Fewer than 50 patients have been described.

Autosomal recessive, which explains the increased risk in consanguineous parents. The mutation has been mapped to 14q13.1.

Purine nucleoside phosphorylase (PNP) is a protein trimer of approximately 90 kDa and present in almost all tissues, but the highest concentration is found in lymphoid tissues. This fact explains why PNP deficiency predominantly affects the lymphatic system. The enzyme is part of the purine salvage pathway and required to catalyze the degradation of (deoxy)inosine and (deoxy)guanosine to hypoxanthine and guanine and, finally, to uric acid. The lack of PNP results in accumulation of deoxyguanosine and deoxyinosine, predominantly in lymphocytes. These two compounds block the enzyme ribonucleotide reductase in T cells, which is used for DNA synthesis (deoxynucleotides), thereby inhibiting the normal T-cell proliferation required for an appropriate immune response. This manifests as defective T-cell immunity and as some degree of B-cell dysfunction.

The combination of neurological defects or recurrent viral infections with undetectable, or extremely low, blood and urine concentrations of uric acid in a child is suggestive of PNP deficiency. In these patients, normally extremely low or even undetectable plasma concentrations of inosine, guanosine, deoxyinosine, and deoxyguanosine are grossly elevated and the same compounds are excreted in excessive amounts in the urine. In severe cases, markedly decreased or even undetectable serum levels of uric acid have been found. The finding of decreased PNP activity in erythrocytes, lymphocytes, or fibroblasts finally confirms the diagnosis. Although heterozygotes show intermediate levels of PNP activity, they appear clinically normal. T-cell function may be normal at birth, but then decreases progressively, although T-cell function may vary to some degree through time.

The thymus is significantly reduced in size and histologic examination reveals depletion of thymocytes. In contrast to severe combined immunodeficiency syndrome, Hassall corpuscles in the thymus are present, but they are not well defined. Lymphoid tissue examination shows abnormalities predominantly in T-cell-dependent areas (paracortical zone). Prenatal diagnosis is possible.

Generally, neurologic symptoms or recurrent or severe viral (e.g., varicella, measles), but also bacterial, fungal (oral candidiasis), mycobacterial, or protozoal infections, with potentially fatal outcome start between the ages of 1 and 5 years. However, symptoms may already occur in the first months of life and include irritability, failure to thrive, hypotonia, lymphopenia, and deficient T-cell-mediated immunity. The B-cell count may be low; however, immunoglobulin levels are often normal, although they may also be decreased or even elevated. About two-thirds of the patients show neurologic symptoms (mental retardation, spastic paraor tetraparesis, ataxia, and tremor). There is an increased incidence of autoimmune hemolytic anemia (in about one-third of the patients) or immune thrombocytopenia, neutropenia, thyroiditis, systemic lupus erythematosus, and B-cell lymphoma. Graft-versus-host disease has been observed in undiagnosed patients receiving transfusion of nonirradiated blood. Immunization with live vaccines in children prior ...

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.